221 related articles for article (PubMed ID: 14676834)
1. Role of the Brk SH3 domain in substrate recognition.
Qiu H; Miller WT
Oncogene; 2004 Mar; 23(12):2216-23. PubMed ID: 14676834
[TBL] [Abstract][Full Text] [Related]
2. Domain interactions in protein tyrosine kinase Csk.
Sondhi D; Cole PA
Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
[TBL] [Abstract][Full Text] [Related]
3. Molecular dissection of the interaction between the SH3 domain and the SH2-Kinase Linker region in PTK6.
Kim HIe; Jung J; Lee ES; Kim YC; Lee W; Lee ST
Biochem Biophys Res Commun; 2007 Nov; 362(4):829-34. PubMed ID: 17822667
[TBL] [Abstract][Full Text] [Related]
4. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin.
Chen HY; Shen CH; Tsai YT; Lin FC; Huang YP; Chen RH
Mol Cell Biol; 2004 Dec; 24(24):10558-72. PubMed ID: 15572663
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Itk tyrosine kinase: contribution of noncatalytic domains to enzymatic activity.
Hawkins J; Marcy A
Protein Expr Purif; 2001 Jul; 22(2):211-9. PubMed ID: 11437596
[TBL] [Abstract][Full Text] [Related]
6. Interaction between Brk kinase and insulin receptor substrate-4.
Qiu H; Zappacosta F; Su W; Annan RS; Miller WT
Oncogene; 2005 Aug; 24(36):5656-64. PubMed ID: 15870689
[TBL] [Abstract][Full Text] [Related]
7. Evidence for SH3 domain directed binding and phosphorylation of Sam68 by Src.
Shen Z; Batzer A; Koehler JA; Polakis P; Schlessinger J; Lydon NB; Moran MF
Oncogene; 1999 Aug; 18(33):4647-53. PubMed ID: 10467411
[TBL] [Abstract][Full Text] [Related]
8. A specific intermolecular association between the regulatory domains of a Tec family kinase.
Brazin KN; Fulton DB; Andreotti AH
J Mol Biol; 2000 Sep; 302(3):607-23. PubMed ID: 10986122
[TBL] [Abstract][Full Text] [Related]
9. A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK.
Mitchell PJ; Sara EA; Crompton MR
Oncogene; 2000 Aug; 19(37):4273-82. PubMed ID: 10980601
[TBL] [Abstract][Full Text] [Related]
10. An intramolecular SH3-domain interaction regulates c-Abl activity.
Barilá D; Superti-Furga G
Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
Brasher BB; Roumiantsev S; Van Etten RA
Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
[TBL] [Abstract][Full Text] [Related]
12. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
[TBL] [Abstract][Full Text] [Related]
13. Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity.
Solheim SA; Petsalaki E; Stokka AJ; Russell RB; Taskén K; Berge T
FEBS J; 2008 Oct; 275(19):4863-74. PubMed ID: 18721137
[TBL] [Abstract][Full Text] [Related]
14. The distinct capacity of Fyn and Lck to phosphorylate Sam68 in T cells is essentially governed by SH3/SH2-catalytic domain linker interactions.
Feuillet V; Semichon M; Restouin A; Harriague J; Janzen J; Magee A; Collette Y; Bismuth G
Oncogene; 2002 Oct; 21(47):7205-13. PubMed ID: 12370810
[TBL] [Abstract][Full Text] [Related]
15. STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation.
Ikeda O; Miyasaka Y; Sekine Y; Mizushima A; Muromoto R; Nanbo A; Yoshimura A; Matsuda T
Biochem Biophys Res Commun; 2009 Jun; 384(1):71-5. PubMed ID: 19393627
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition.
Qiu H; Miller WT
J Biol Chem; 2002 Sep; 277(37):34634-41. PubMed ID: 12121988
[TBL] [Abstract][Full Text] [Related]
17. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
Eck MJ; Atwell SK; Shoelson SE; Harrison SC
Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
[TBL] [Abstract][Full Text] [Related]
18. Regulatory intramolecular association in a tyrosine kinase of the Tec family.
Andreotti AH; Bunnell SC; Feng S; Berg LJ; Schreiber SL
Nature; 1997 Jan; 385(6611):93-7. PubMed ID: 8985255
[TBL] [Abstract][Full Text] [Related]
19. UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug.
Oneyama C; Nakano H; Sharma SV
Oncogene; 2002 Mar; 21(13):2037-50. PubMed ID: 11960376
[TBL] [Abstract][Full Text] [Related]
20. An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6.
Kim HIe; Lee ST
J Biol Chem; 2005 Aug; 280(32):28973-80. PubMed ID: 15961400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
